News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
170,109 Results
Type
Article (7982)
Company Profile (109)
Press Release (162018)
Section
Business (57457)
Career Advice (263)
Deals (9938)
Drug Delivery (18)
Drug Development (22471)
Employer Resources (22)
FDA (4155)
Job Trends (4567)
News (92010)
Policy (6540)
Tag
Academia (598)
Accelerated approval (5)
Adcomms (4)
Allergies (32)
Alliances (8759)
ALS (22)
Alzheimer's disease (444)
Antibody-drug conjugate (ADC) (28)
Approvals (4242)
Artificial intelligence (77)
Autoimmune disease (11)
Automation (7)
Bankruptcy (50)
Best Places to Work (3757)
BIOSECURE Act (5)
Biosimilars (29)
Biotechnology (73)
Bladder cancer (40)
Brain cancer (10)
Breast cancer (147)
Cancer (1006)
Cardiovascular disease (90)
Career advice (231)
Career pathing (4)
CAR-T (50)
CDC (4)
Cell therapy (151)
Cervical cancer (14)
Clinical research (19958)
Collaboration (230)
Compensation (136)
Complete response letters (10)
COVID-19 (670)
CRISPR (13)
C-suite (43)
Cystic fibrosis (29)
Data (1327)
Depression (18)
Diabetes (110)
Diagnostics (1729)
Digital health (5)
Diversity, equity & inclusion (7)
Drug discovery (42)
Drug pricing (15)
Drug shortages (6)
Duchenne muscular dystrophy (43)
Earnings (41040)
Editorial (10)
Employer branding (2)
Employer resources (21)
Events (25986)
Executive appointments (115)
FDA (4891)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (190)
Gene editing (32)
Generative AI (6)
Gene therapy (117)
GLP-1 (245)
Government (1024)
Grass and pollen (2)
Guidances (275)
Healthcare (5405)
HIV (15)
Huntington's disease (10)
IgA nephropathy (22)
Immunology and inflammation (57)
Immuno-oncology (2)
Indications (14)
Infectious disease (719)
Inflammatory bowel disease (36)
Inflation Reduction Act (1)
Influenza (21)
Intellectual property (27)
Interviews (27)
IPO (6063)
IRA (5)
Job creations (1005)
Job search strategy (213)
Kidney cancer (5)
Labor market (20)
Layoffs (136)
Leadership (1)
Legal (1126)
Liver cancer (16)
Longevity (3)
Lung cancer (175)
Lymphoma (97)
Machine learning (5)
Management (6)
Manufacturing (121)
MASH (27)
Medical device (3541)
Medtech (3546)
Mergers & acquisitions (4161)
Metabolic disorders (258)
Multiple sclerosis (39)
NASH (5)
Neurodegenerative disease (34)
Neuropsychiatric disorders (5)
Neuroscience (652)
NextGen: Class of 2025 (1617)
Non-profit (1095)
Now hiring (17)
Obesity (120)
Opinion (35)
Ovarian cancer (37)
Pain (36)
Pancreatic cancer (35)
Parkinson's disease (55)
Partnered (7)
Patents (69)
Patient recruitment (55)
Peanut (15)
People (7614)
Pharmaceutical (29)
Pharmacy benefit managers (4)
Phase I (5137)
Phase II (8694)
Phase III (7662)
Pipeline (1288)
Policy (26)
Postmarket research (741)
Preclinical (1593)
Press Release (21)
Prostate cancer (46)
Psychedelics (11)
Radiopharmaceuticals (41)
Rare diseases (147)
Real estate (1252)
Recruiting (10)
Regulatory (5131)
Reports (16)
Research institute (556)
Resumes & cover letters (25)
Rett syndrome (8)
RNA editing (4)
RSV (8)
Schizophrenia (36)
Series A (27)
Series B (19)
Service/supplier (2)
Sickle cell disease (20)
Special edition (8)
Spinal muscular atrophy (43)
Sponsored (9)
Startups (660)
Stomach cancer (5)
Supply chain (16)
Tariffs (15)
The Weekly (2)
Vaccines (207)
Venture capital (17)
Weight loss (73)
Women's health (11)
Worklife (3)
Date
Last 7 days (131)
Last 30 days (563)
Last 365 days (9350)
2025 (6566)
2024 (10446)
2023 (11613)
2022 (14906)
2021 (15943)
2020 (14822)
2019 (12472)
2018 (9381)
2017 (8561)
2016 (7839)
2015 (9225)
2014 (6215)
2013 (4298)
2012 (4974)
2011 (5418)
2010 (4452)
Location
Africa (159)
Alabama (14)
Arizona (44)
Arkansas (1)
Asia (9969)
Australia (1763)
California (2548)
Canada (707)
China (213)
Colorado (100)
Connecticut (85)
Delaware (93)
Europe (24318)
Florida (360)
Georgia (85)
Idaho (11)
Illinois (185)
India (11)
Indiana (125)
Iowa (5)
Japan (85)
Kansas (26)
Kentucky (9)
Louisiana (8)
Maine (13)
Maryland (350)
Massachusetts (1830)
Michigan (60)
Minnesota (182)
Mississippi (2)
Missouri (20)
Montana (15)
Nebraska (3)
Nevada (45)
New Hampshire (29)
New Jersey (949)
New Mexico (4)
New York (697)
North Carolina (355)
Northern California (1193)
Ohio (67)
Oklahoma (5)
Oregon (8)
Pennsylvania (475)
Rhode Island (13)
South America (296)
South Carolina (3)
South Dakota (1)
Southern California (1006)
Tennessee (23)
Texas (361)
United States (9231)
Utah (77)
Virginia (34)
Washington D.C. (17)
Washington State (222)
West Virginia (1)
Wisconsin (30)
170,109 Results for "40".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study
Despite hitting its efficacy targets in the Phase III COAST-1 study, Sanofi’s amlitelimab remains “meaningfully inferior” to Dupixent, according to analysts at Leerink Partners.
September 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Alligator Announces Publication in Cancer Immunology Research of Preclinical Data on ATOR-4066, a Tumor-Directed CD40×CEACAM5 Bispecific Antibody
September 11, 2025
·
2 min read
Press Releases
Leukemia Therapeutics Market Size to Reach USD 40.11 Billion By 2034
July 9, 2025
·
1 min read
Press Releases
Ashvattha Therapeutics Announces Positive Topline 40-Week Phase 2 Results for Migaldendranib in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
September 5, 2025
·
5 min read
Drug Pricing
BMS, Pfizer Join DTC Trend, Offering Eliquis to Patients for 40% Below List Price
In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer pitched the direct-to-consumer program as a way to allow uninsured, underinsured and self-pay patients to pay less out of pocket.
July 17, 2025
·
2 min read
·
Nick Paul Taylor
Press Releases
AvenCell Awarded Up to $40 Million AMED Grant to Advance Allogeneic CAR-T Program
July 1, 2025
·
2 min read
Layoffs
Rallybio Downsizes by 40% After Dropping Lead Asset
The company discontinued development last month of its most mature asset, RLYB212, following disappointing mid-stage pharmacokinetic findings in a rare bleeding disorder.
May 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Computer Vision for Drug Manufacturing Market Expands in 2025 Backed by Pharma 4.0 and Government-Led AI Initiatives
July 8, 2025
·
1 min read
Press Releases
Somatic Therapy Market to Reach USD 12.40 Billion by 2032 at 17.5% CAGR: Coherent Market Insights
July 1, 2025
·
1 min read
Press Releases
Blarcamesine Market to Reach USD 1,082.8 Million, Globally by 2032 at 4.0% CAGR
June 10, 2025
·
1 min read
1 of 17,011
Next
